Johansen JS - Search Results

1

Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma.

Mylin AK, Abildgaard N, Johansen JS, Heickendorff L, Kreiner S, Waage A, Turesson I, Gimsing P; Nordic Myeloma Study Group. Mylin AK, et al. Among authors: johansen js. Leuk Lymphoma. 2015;56(9):2650-9. doi: 10.3109/10428194.2015.1004168. Epub 2015 Feb 11. Leuk Lymphoma. 2015. PMID: 25573204

2

Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.

Kronborg G, Ostergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, Price PA, Johansen JS. Kronborg G, et al. Among authors: johansen js. Scand J Infect Dis. 2002;34(5):323-6. doi: 10.1080/00365540110080233. Scand J Infect Dis. 2002. PMID: 12069012

3

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.

Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Cintin C, et al. Among authors: johansen js. Cancer. 2002 Jul 15;95(2):267-74. doi: 10.1002/cncr.10644. Cancer. 2002. PMID: 12124825 Free article.

4

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.

Dehn H, Høgdall EV, Johansen JS, Jørgensen M, Price PA, Engelholm SA, Høgdall CK. Dehn H, et al. Among authors: johansen js. Acta Obstet Gynecol Scand. 2003 Mar;82(3):287-93. doi: 10.1034/j.1600-0412.2003.00010.x. Acta Obstet Gynecol Scand. 2003. PMID: 12694127 Free article.

5

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK. Høgdall EV, et al. Among authors: johansen js. Oncol Rep. 2003 Sep-Oct;10(5):1535-8. Oncol Rep. 2003. PMID: 12883737

6

High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.

Jensen BV, Johansen JS, Price PA. Jensen BV, et al. Among authors: johansen js. Clin Cancer Res. 2003 Oct 1;9(12):4423-34. Clin Cancer Res. 2003. PMID: 14555515

7

High serum YKL-40 level in patients with small cell lung cancer is related to early death.

Johansen JS, Drivsholm L, Price PA, Christensen IJ. Johansen JS, et al. Lung Cancer. 2004 Dec;46(3):333-40. doi: 10.1016/j.lungcan.2004.05.010. Lung Cancer. 2004. PMID: 15541818

8

Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?

Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Johansen JS, et al. Respir Med. 2005 Apr;99(4):396-402. doi: 10.1016/j.rmed.2004.09.016. Epub 2004 Nov 5. Respir Med. 2005. PMID: 15763444 Free article.

9

High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia.

Bergmann OJ, Johansen JS, Klausen TW, Mylin AK, Kristensen JS, Kjeldsen E, Johnsen HE. Bergmann OJ, et al. Among authors: johansen js. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8644-52. doi: 10.1158/1078-0432.CCR-05-1317. Clin Cancer Res. 2005. PMID: 16361549

10

Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.

Brasso K, Christensen IJ, Johansen JS, Teisner B, Garnero P, Price PA, Iversen P. Brasso K, et al. Among authors: johansen js. Prostate. 2006 Apr 1;66(5):503-13. doi: 10.1002/pros.20311. Prostate. 2006. PMID: 16372331 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters